Aquila provides cost-effective, accurate and timely nucleic acid-based point-of-care diagnostic testing for infectious diseases from unprocessed samples. Our technology is extremely robust, with successful laboratory and field-testing across human (malaria), animal, water, and aquaculture targets. We are preparing to commercialize worldwide, including markets in North America and Europe.

Latest News

posted on November 25, 2014 First Aquila Patent Allowed by USPTO
November 18, 2014 – Aquila Diagnostic Systems Inc. received notice today that the United States Patent and Trademark Office (USPTO) has allowed its first Patent Application.

-
-

posted on July 08, 2014 Accutas™ Lab-On-A-Chip Malaria Detection Kit Featured on ABC News
July 8, 2014  - Australia -  Aquila's Accutas™ Lab-On-A-Chip malaria detection kit and Dr. Stephanie Yanow are featured on ABC News.

-
-

posted on June 28, 2014 Aquila Receives Federal WINN Funding
June 27, 2014 - Calgary, AB, Canada - Aquila receives new Federal Government funding under the Western Innovation (WINN) Initiative at an announcement today.

-
-

posted on June 24, 2014 Research showing the effectiveness of Aquila's Accutas™ Lab-On-A-Chip published in Malaria Journal
Research into Aquila's Accutas™ Lab-On-A-Chip system published in the May 2014 issue of Malaria Journal shows the technology's effectiveness at diagnosing malaria. Using patient samples from Uganda, the diagnostic exceeded the standards for microscopy by ten- to fifty-fold, with sensitivity (97.4%) and specificity (93.8%) compared to conventional real-time PCR.

-
-

posted on March 24, 2014 Aquila's Accutas™ Lab-On-A-Chip Featured in Apple Magazine
March 24, 2014 - Edmonton, AB, Canada - The Accutas™ system is recognized among groundbreaking healthcare innovations in Alberta Health Service's Apple magazine.

-
-

posted on March 13, 2014 Aquila Diagnostic Systems Unveils New Accutas™ Lab-On-A-Chip March 13, 2014 – Edmonton, AB, Canada – With a favourable assessment from the Geneva-based Foundation for Innovative New Diagnostics (FIND), Edmonton's Aquila Diagnostic Systems has achieved an important milestone in the development of their point-of-care Accutas™ Lab-On-A-Chip malaria detection kit. 

-
-

posted on November 08, 2013 Aquila featured in Alberta Venture Magazine October 1, 2013  - Edmonton, AB, Canada - Aquila's backstory as a fledgling startup company gaining steam is profiled in Alberta Venture. 

-
-

Testimonials

“Having something that can be out in the field, that can be affordable at a more local level and that doesn't need sophisticated laboratory technicians or laboratory equipment is going to be really invaluable.” 
Dr. Maxine Whittaker, Co-Secretariat of the Asia Pacific Malaria Elimination Network (APMEN) and Professor of International and Tropical Health of the School of Public Health at the University of Queensland, Australia.
 
 
 

Supporters

Alberta Innovates
Broadport Canada Inc
nanobridge small
Western Economic Diversification Canada 120w

9207 117 Street, Edmonton, Alberta, Canada   T6G 1S3

   Subscribe to our newsletter